Correlation Between Bristol-Myers Squibb and Mars Bancorp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol-Myers Squibb and Mars Bancorp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol-Myers Squibb and Mars Bancorp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Mars Bancorp, you can compare the effects of market volatilities on Bristol-Myers Squibb and Mars Bancorp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol-Myers Squibb with a short position of Mars Bancorp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol-Myers Squibb and Mars Bancorp.

Diversification Opportunities for Bristol-Myers Squibb and Mars Bancorp

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bristol-Myers and Mars is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Mars Bancorp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mars Bancorp and Bristol-Myers Squibb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Mars Bancorp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mars Bancorp has no effect on the direction of Bristol-Myers Squibb i.e., Bristol-Myers Squibb and Mars Bancorp go up and down completely randomly.

Pair Corralation between Bristol-Myers Squibb and Mars Bancorp

Assuming the 90 days horizon Bristol Myers Squibb is expected to under-perform the Mars Bancorp. But the pink sheet apears to be less risky and, when comparing its historical volatility, Bristol Myers Squibb is 1.09 times less risky than Mars Bancorp. The pink sheet trades about 0.0 of its potential returns per unit of risk. The Mars Bancorp is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  1,369  in Mars Bancorp on November 2, 2024 and sell it today you would lose (84.00) from holding Mars Bancorp or give up 6.14% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy42.37%
ValuesDaily Returns

Bristol Myers Squibb  vs.  Mars Bancorp

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile primary indicators, Bristol-Myers Squibb may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Mars Bancorp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mars Bancorp has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Mars Bancorp is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.

Bristol-Myers Squibb and Mars Bancorp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol-Myers Squibb and Mars Bancorp

The main advantage of trading using opposite Bristol-Myers Squibb and Mars Bancorp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol-Myers Squibb position performs unexpectedly, Mars Bancorp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mars Bancorp will offset losses from the drop in Mars Bancorp's long position.
The idea behind Bristol Myers Squibb and Mars Bancorp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Stocks Directory
Find actively traded stocks across global markets
Transaction History
View history of all your transactions and understand their impact on performance
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios